Int J Nanomedicine. 2017 Aug 23;12:6169-6184. doi: 10.2147/IJN.S141069. eCollection 2017

Vaccination with poly(D,L-lactide-co-glycolide) nanoparticles loaded with soluble Leishmania antigens and modified with a TNFα-mimicking peptide or monophosphoryl lipid A confers protection against experimental visceral leishmaniasis.

Margaroni M^1,2, Agallou M¹, Athanasiou E¹, Kammona O³, Kiparissides C^3,4, Gaitanaki C², Karagouni E¹.

¹Laboratory of Cellular Immunology, Department of Microbiology, Hellenic Pasteur Institute. 
²Department of Animal and Human Physiology, School of Biology, National and Kapodistrian University of Athens, Athens.
³Chemical Process & Energy Resources Institute, Centre for Research and Technology Hellas.
⁴Department of Chemical Engineering, Aristotle University of Thessaloniki, Thessaloniki, Greece.